Professional Documents
Culture Documents
The right answer was The removal of drug is independent of drug concentration.
Question 2
The right answer was Excretion rate.
Question 3
Question 4
The right answer was All are correct.
Question 5
The right answer was 2.4 mg.
Question 6
The right answer was 1.25 mg.
Question 7
The right answer was 30 L/hr/70 Kg.
Question 8
The right answer was a & b.
Question 9
Question 10
The right answer was CYP51.
Question 11
The right answer was All of the above.
Question 12
The right answer was Both carry out oxidative deaminations.
Question 13
The right answer was Glucuronide conjugation.
Question 14
The right answer was Hydroxylation.
Question 15
The right answer was Decrease.
In a zero order elimination process, which of the
following is true?
The removal of drug is independent of drug concentration
Cl = Elimination rate/Cp
t1/2 = .7VD/Cl
All are true
Pharmacology 2
Question 1
Flumazenil
Question 2
The right answer was CaEDTA.
Question 3
liver
Question 4
The right answer was Thalamus hypertrophy.
Question 5
Quinidine
Question 6
The right answer was Isoniazid.
Question 7
Ethosuximide
Question 8
The right answer was Fluoroquinolones.
Question 9
The right answer was ACE inhibitor.
Question 10
Antifungal
Question 11
H2 agonist
Question 12
Protease inhibitor
Question 13
The right answer was Tetracycline.
Question 14
The right answer was Hypotension.
Question 15
The right answer was Tachycardia.
Question 16
The right answer was Aminodarone.
Question 17
The right answer was Propafenone.
Question 18
Question 20
The right answer was Muscle wasting.
Flumazenil
Methylene blue
Deferoxamine
Alkalinize urine
Naloxone
Nitrite
CaEDTA
Dialysis
Which of the following is the primary site of activity for the drug Warfarin?
Kidney
Liver
Blood
Heart
Gastritis
Peptic Ulcers
Zollinger-Ellison syndrome
Thalamus hypertrophy
Valproic acid
Quinidine
Isoniazid
Ethosuximide
Valproic acid
Quinidine
Isoniazid
Ethosuximide
Valproic acid
Quinidine
Isoniazid
Ethosuximide
Which of the following drugs is associated with the reaction of Tendon dyfunction?
Digitalis
Niacin
Tetracycline
Fluoroquinolones
H2 agonist
ACE inhibitor
Antifungal
Beta agonist
H2 agonist
ACE inhibitor
Antifungal
Beta agonist
Antidepressant
Protease inhibitor
Beta antagonist
H2 antagonist
Antidepressant
Protease inhibitor
Beta antagonist
H2 antagonist
Digitalis
Niacin
Tetracycline
Fluoroquinolones
Cataracts
Hypotension
Psychosis
Acne
CHF
Tachycardia
AV block
Sedative appearance
Mexiletine
Aminodarone
Quinidine
Procainamide
Propafenone
Disopyramide
Aminodarone
Quinidine
Potassium sparing diuretics have the primary effect upon the _____ found in the
kidney.
Headaches
Tachycardia
Dizziness
Projectile vomiting
Nausea
Renal dysfunction
Anemia
Muscle wasting
Website: Pharmainfo.net
Active learning center
Test prepreview
Pharmacology
A. Pregnancy
B. Hyperlipidemia
C. Diabetes
D. Diabetes mellitus *
E. Hearing impairment
A. beta-2 agonist
B. Inhibits RNA-dependent RNA polymerase
C. Inhibits reverse transcriptase
D. Inhibits viral protease *
E. Stimulates lipoprotein lipase
A. NSAID
B. Antidepressants
C. Autonomic nervous system drugs
D. Antivirals *
E. Oral hypoglycemics
A. Streptococcus pneumoniae *
B. Varicella zoster virus
C. Myocardial infarction
D. Generalized motor seizures
E. Bone marrow failure states (aplastic anemia, myelodysplasias) (investigational)
A. Thiazides
B. Antiprotozoan agents
C. Autonomic nervous system drugs
D. Polyenes *
E. Oral hypoglycemics
Mechanism of action of isoetharine is:
A. Inhibits phosphodiesterase
B. Reduces calcium influx into neurons
C. Potentiates glucose-mediated insulin secretion
D. Inhibits phospholipase A2
E. beta-2 agonist *
A. Anticonvulsants
B. Lipid lowering drugs
C. Beta blockers
D. Benzodiazepines
E. Sedatives *
A. Gout
B. Diabetes mellitus
C. Hyperlipidemia
D. Liver disease
E. Late pregnancy *
A. Liver *
B. None
C. Reticuloendothelial system
D. Leukocytes
E. Unknown
A. 10-50 hours
B. 8 hours
C. 1 hour
D. 16 hours
E. 3-4 hours *
A. Glucocorticosteroids
B. Anti-asthmatic agents
C. Polyenes
D. Antivirals *
E. Autonomic nervous system drugs
A. Seizures
B. Skin rash
C. Nausea
D. Urinary tract complications
E. Myalgia *
A. dopamine antagonist
B. Unknown
C. Holds water in stool
D. Potassium channel agonist
E. Stimulates guanylate cyclase *
A. Azoles
B. ACE inhibitors
C. Retinoids
D. Dehydropeptidase I inhibitors *
E. K sparing diuretics
A. Intramuscular *
B. Inhalation
C. Topical
D. Oral
E. Intra-auricular
A. Benzodiazepine intoxication
B. Hypercalcemia
C. Kaposi's sarcoma
D. Streptococcus pneumoniae *
E. Angina
A. Pain
B. Movement disorders
C. Thyrotoxicosis - preparation for radioactive iodine therapy
D. Anaphylactic shock
E. Acute hypertension *
A. Fatal overdosage rare unless taken with alcohol or other CNS depressants.
B. Choice between quinidine and disopyramide should be made based on side
effects. In patients with AV conduction problems or quinidine-induced GI toxicity,
disopyramide ought to be chosen. In patients with MI or anticholinergic side
effects, quinidine is the agent of choice.
C. Less effective than tricyclics or ECT in unipolar depression.
D. Is metabolized to several substances with long (>24 hours) half lives. These do
not contribute to anticonvulsant effect but do contribute to sedative effect.
E. No difference in effects between elderly and average population *
A. Aquaretics
B. Alkylating agents *
C. Lipid lowering drugs
D. Drugs affecting calcium homeostasis
E. Antivirals
A. Glaucoma
B. Migraine prophylaxis
C. Thyrotoxicosis - preparation for radioactive iodine therapy *
D. Severe recurrent ventricular tachyarrhythmias
E. Broad spectrum antibacterial agent
Half-life of adenosine is:
A. 70 days
B. 7-20 hours
C. 4 hours
D. 2 hours
E. 1-2 minutes *
A. Unknown
B. Kidneys *
C. Intestines
D. Liver
A. Inorganic nitrates
B. Potassium channel agonists
C. Surface active agents
D. Organic nitrates *
E. Phenylpiperidine
A. Streptococcus pneumoniae
B. Cytomegalovirus retinitis
C. Diarrhea
D. Influenza A
E. HIV *
Route of administration of ofloxacin is:
A. Intra-auricular
B. Sublingual
C. Oral *
D. IV
E. Intramuscular
A. Analgesics
B. Inotropic agents
C. Penicillins
D. Antithyroid agents
E. Aquaretics *
A. Inhibits topoisomerase II *
B. alpha antagonist
C. Inhibits peptidyl transferase
D. beta antagonist
E. Allosterically enhances GABAergic inhibition
A. Diarrhea
B. Headache *
C. Bleeding
D. Hypercalcemia
E. Pseudothrombocytopenia (clumping of platelets)
A. May induce mild hypotension and worsen congestive heart failure in some
patients. However, most CHF patients can tolerate it.
B. Duration of action is usually several days.
C. Has been show to be more effective than six other agents in preventing arrhythmia
recurrence and death in patients with ventricular tachyarrhythmias.
D. Is effective against erythrocytic forms.
E. Used in emergency setting during attempted resuscitation when lidocaine and
cardioversion have failed. *
A. Bronchospasm
B. Hypotension
C. GI toxicity
D. Oral and GI ulcers *
E. Dysphonia
A. Nausea *
B. Mucositis
C. Constipation
D. Hearing impairment
E. Weight gain
A. Antifolates *
B. Antivirals
C. Aquaretics
D. Autonomic nervous system drugs
E. H2 antagonists
A. Subcutaneous
B. Inhalation
C. Intrathecal
D. Oral *
E. Transdermal
A. In Tuberculosis
B. Migraine prophylaxis
C. Tricyclic antidepressant poisoning
D. Broad spectrum antibacterial agent *
E. Asthma
A. Insomnia
B. Cyanide poisoning
C. Cardiac arrest
D. Inflammation *
E. Subarachnoid hemorrhage
A. Anticoagulants
B. Methylxanthines
C. Inotropic agents
D. Antiarrhythmic agents
E. Autonomic nervous system drugs *
A. Fluoroquinolones *
B. IA
C. Calciferols
D. Beta-lactamase resistant penicillins
E. Aldosterone antagonists
A. opiate agonist
B. Blocks sustained repetitive neuronal firing
C. beta-2 agonist *
D. Inhibits phospholipase A2
E. Inhibits phospholipase C
A. Vasodilators
B. Sulfonamides
C. Tetracyclines
D. H2 antagonists *
E. Antimycobacterial
A. None
B. Kidneys
C. Liver *
D. Unknown
E. Reticuloendothelial system
A. Asthma
B. Nausea
C. Cataracts *
D. Anxiety
E. Hyperglycemia
A. Cestodes
B. Status epilepticus
C. Strongyloides stercoralis *
D. Ancylostoma duodenale
E. Ventricular fibrillation
A. Myalgia
B. Restlessness
C. Cognitive dulling
D. Dyspnea *
E. Cough
A. Analgesics
B. Glucocorticosteroids
C. Methylxanthines
D. Antidiarrheal agents *
E. Antiarrhythmic agents
A. NSAID
B. Autonomic nervous system drugs *
C. Antiarrhythmic agents
D. Inotropic agents
E. Beta blockers
A. Sedatives
B. Anti-asthmatic agents
C. Antimycobacterial
D. Antidepressants
E. Thrombolytics *
A. III
B. Fluoroquinolones *
C. IC
D. Bulk-forming laxatives
E. II
A. Retinoids
B. Anti-asthmatic agents
C. Autonomic nervous system drugs *
D. Loop diuretics
E. Antiarrhythmic agents
A. Sulfonylureas *
B. Organic nitrates
C. Alpha-glucosidase inhibitors
D. Potassium channel agonists
E. Biguanides
A. Migraine prophylaxis
B. Bipolar disorder
C. Myoclonic seizures *
D. Thyrotoxicosis - preparation for surgery
E. Trigeminal neuralgia
A. Inhalation
B. Subcutaneous
C. IV
D. Oral *
E. Sublingual
A. Antidepressants *
B. Aquaretics
C. Autonomic nervous system drugs
D. Laxatives
E. Anti-asthmatic agents
A. H2 antagonists
B. Macrolides
C. Cathartics *
D. Analgesics
E. Lipid lowering drugs
A. Thiazides
B. Antiarrhythmic agents *
C. Cephalosporins
D. Autonomic nervous system drugs
E. Beta blockers
A. 12-24 hours
B. 3 hours
C. 6-12 hours *
D. 10 hours
E. 8 hours
A. Antiarrhythmic agents
B. Antithyroid agents
C. Anticonvulsants
D. Beta blockers *
E. Antidepressants
A. Pyrophosphate analog *
B. Metabolism in liver is by glucuronidization
C. Not shown to reduce sudden death or prolong survival.
D. Inhibition of DNA gyrase results in: 1. Inhibition of bacterial replication 2.
Inhibition of DNA repair 3. Inhibition of expression of certain operons
E. Non-nucleoside reverse transcriptase inhibitor
A. Inhibits transpeptidase *
B. Blocks Na channels
C. Activates heparin cofactor II which inhibits thrombin (at high concentrations)
D. Blocks sustained repetitive neuronal firing
E. GM-CSF